Ugur Musabak

Ugur Musabak

Auto-generated profile, based on publicly available information

Ugur Musabak

Department of Immunology, Gülhane Military Medical Academy, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
LSLevent Sutcigil
Levent Sutcigil
COCagatay Oktenli
Cagatay Oktenli
UMUgur Musabak
Ugur Musabak
ABAli Bozkurt
Ali Bozkurt
ACAdnan Cansever
Adnan Cansever
ASAli Sengul
Ali Sengul
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.

1 April 2005 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
ZYZeki Yesilova
Zeki Yesilova
HYHalil Yaman
Halil Yaman
COCagatay Oktenli
Cagatay Oktenli
AOAyhan Ozcan
Ayhan Ozcan
AUAhmet Uygun
Ahmet Uygun
KDKemal Dagalp
Kemal Dagalp
The aim of the present study was to examine the systemic parameters of oxidative stress and antioxidants in patients with nonalcoholic fatty liver disease and investigate the relationship between these parameters and clinical and biochemical outcomes. Fifty-one male patients with nonalcoholic fatty liver disease (group I), 30 age-matched and body mass index (BMI)-matched healthy male subjects, and 30 age-matched male patients with chronic viral hepatitis (group II) were enrolled in the study. Increased systemic levels of malondialdehyde and depletion of antioxidants such as coenzyme Q10, CuZn-superoxide dismutase, and catalase activity were observed in group I. Coenzyme Q10 and CuZn-superoxide dismutase correlated negatively with increasing necroinflammatory activity and fibrosis. Body fat was negatively associated with plasma coenzyme Q10 levels, while an inverse association was found between plasma catalase levels and TG. However, LDL was positively associated with plasma malondialdehyde levels. CuZn-superoxide dismutase levels were negatively associated with glucose, insulin, and HOMA-IR. In addition, the levels of CuZn-superoxide dismutase correlated significantly in a negative manner with BMI. Our results concerning correlations suggest that disturbances in BMI, body fat, and lipid metabolism may contribute to altered oxidative status in NAFLD, and insulin resistance may be related to decreased antioxidants in NAFLD as well as products of lipid peroxidation. However, although our results suggest interesting correlations, this different mostly “weak” relationships must be taken with caution.

10 April 2017 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
HEHakan Erdem
Hakan Erdem
AIA. Inan
A. Inan
EGE. Guven
E. Guven
SHSally Hargreaves
Sally Hargreaves
LLLykke Larsen
Lykke Larsen
MNM. Nassar
M. Nassar

5 October 2005 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
UMU. Musabak
U. Musabak
SPS. Pay
S. Pay
HEH. Erdem
H. Erdem
ISI. Simsek
I. Simsek
APA. Pekel
A. Pekel
ASA. Sengul
A. Sengul

1 August 2012 in Chest
Verified
Journal Article
Closed access
PDF file
HKHatice Kaya
Hatice Kaya
SGSeyfettin Gümüş
Seyfettin Gümüş
EUErgun Uçar
Ergun Uçar
MAMehmet Aydoğan
Mehmet Aydoğan
UMUğur Muşabak
Uğur Muşabak
HBHayati Bilgiç
Hayati Bilgiç

17 August 2010 in Neuroimmunomodulation
Verified
Journal Article
Closed access
UMUgur Musabak
Ugur Musabak
SDSeref Demirkaya
Seref Demirkaya
GGGencer Genç
Gencer Genç
RIRahsan Sagkan Ilikci
Rahsan Sagkan Ilikci
ZOZeki Odabaşı
Zeki Odabaşı
Objectives: Multiple sclerosis (MS) is a chronic inflammatory disease of the human central nervous system. In the present study, we aimed to determine adiponectin, tumor necrosis factor-α, interleukin (IL)-12p70, and IL-13 levels in the sera of patients with MS and to investigate the effects of interferon (IFN), glatiramer acetate (GA), and immunosuppressive treatment regimens on these parameters. Methods: Fifty-seven patients with MS and 34 healthy controls were enrolled into the study. Serum cytokine levels were measured using enzyme immunoassay. Results: Significantly elevated levels of IL-12p70 and IL-13 were found in the sera of patients with MS, but decreased adiponectin levels were found in patients’ sera compared to healthy controls. The levels of IL-12p70 and IL-13 in the IFN therapy group were higher than those of the healthy controls. However, the IL-12p70 and IL-13 levels in the GA therapy group were not different from those of the healthy controls. There were no differences with regard to adiponectin levels among the subgroups of patients with MS according to therapy regimen and the healthy controls. At the end of a 2-year follow-up period, Expanded Disability Status Scale (EDSS) values were found to be increased in the IFN therapy group but unchanged in the GA therapy group. Conclusions: These findings suggest that adiponectin, IL-12p70, and IL-13 may play a role in the pathogenesis of MS. Additionally, GA therapy regimens in MS are more effective than IFN therapy with respect to decreasing the levels of IL-12p70 and IL-13 and stabilizing the EDSS value.